BR112014014786A2 - antibiotic formulations - Google Patents

antibiotic formulations

Info

Publication number
BR112014014786A2
BR112014014786A2 BR112014014786A BR112014014786A BR112014014786A2 BR 112014014786 A2 BR112014014786 A2 BR 112014014786A2 BR 112014014786 A BR112014014786 A BR 112014014786A BR 112014014786 A BR112014014786 A BR 112014014786A BR 112014014786 A2 BR112014014786 A2 BR 112014014786A2
Authority
BR
Brazil
Prior art keywords
antibiotic formulations
antibiotic
suspension formulation
formulations
administration
Prior art date
Application number
BR112014014786A
Other languages
Portuguese (pt)
Inventor
Al Alawi Fadil
Nanjan Karthigeyan
Original Assignee
Bayer New Zealand Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48668892&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014014786(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer New Zealand Ltd filed Critical Bayer New Zealand Ltd
Publication of BR112014014786A2 publication Critical patent/BR112014014786A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0068—Rumen, e.g. rumen bolus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

1/1 resumo "formulações de antibiótico", uma formulação de suspensão para administração a um animal, a formulação de suspensão incluindo: pelo menos um antibiótico de cefalosporina ou um sal farmaceuticamente semelhante; um óleo; e um solvente de acetato de glicerol.1/1 summary "antibiotic formulations" means a suspension formulation for administration to an animal, a suspension formulation comprising: at least one cephalosporin antibiotic or a pharmaceutically similar salt; an oil; and a glycerol acetate solvent.

BR112014014786A 2011-12-23 2012-12-21 antibiotic formulations BR112014014786A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ59738911 2011-12-23
PCT/NZ2012/000245 WO2013095166A1 (en) 2011-12-23 2012-12-21 Antibiotic formulations

Publications (1)

Publication Number Publication Date
BR112014014786A2 true BR112014014786A2 (en) 2017-06-13

Family

ID=48668892

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014014786A BR112014014786A2 (en) 2011-12-23 2012-12-21 antibiotic formulations

Country Status (15)

Country Link
KR (1) KR20140102319A (en)
CN (1) CN104080456A (en)
AU (1) AU2012359296B2 (en)
BR (1) BR112014014786A2 (en)
CL (1) CL2014001602A1 (en)
CO (1) CO7101241A2 (en)
CR (1) CR20140355A (en)
DO (1) DOP2014000146A (en)
IL (1) IL233299A0 (en)
MX (1) MX2014007735A (en)
MY (1) MY167596A (en)
NI (1) NI201400064A (en)
PE (1) PE20142373A1 (en)
PH (1) PH12014501384A1 (en)
WO (1) WO2013095166A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX358248B (en) 2012-07-17 2018-08-10 Bayer New Zealand Ltd Injectable antibiotic formulations and their methods of use.
US9452155B2 (en) 2012-07-17 2016-09-27 Bayer New Zealand Ltd Injectable antibiotic formulations and their methods of use
MX2021010689A (en) * 2019-03-06 2021-10-01 Zoetis Services Llc Ready-to-use injectable formulations.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2013755C (en) * 1989-04-05 1993-11-30 Simon Benita Medicinal emulsions
KR20040015622A (en) * 2002-08-13 2004-02-19 대한뉴팜(주) Injectable Composition Comprising Ceftiofur Sodium as Active Ingredient
CN1517090A (en) * 2003-01-20 2004-08-04 王玉万 Animal use suspensoid injection or emulsion containing antibacterial medicine
US7767860B2 (en) * 2007-09-06 2010-08-03 Auspex Pharmaceuticals, Inc Substituted amino alcohols
CN101401787B (en) * 2008-11-19 2011-05-18 肖希龙 Ceftiofur long-acting injection and preparation method thereof
CN101953889B (en) * 2010-09-07 2013-04-10 西北农林科技大学 Compound ceftiofur suspension emulsion injection and preparation method thereof

Also Published As

Publication number Publication date
WO2013095166A1 (en) 2013-06-27
PH12014501384A1 (en) 2014-09-22
IL233299A0 (en) 2014-08-31
CL2014001602A1 (en) 2014-10-24
AU2012359296B2 (en) 2014-12-11
DOP2014000146A (en) 2014-07-31
CN104080456A (en) 2014-10-01
AU2012359296A1 (en) 2013-08-01
KR20140102319A (en) 2014-08-21
CO7101241A2 (en) 2014-10-31
MY167596A (en) 2018-09-20
MX2014007735A (en) 2014-08-01
PE20142373A1 (en) 2015-02-11
CR20140355A (en) 2014-10-29
NI201400064A (en) 2014-11-28

Similar Documents

Publication Publication Date Title
EA201592055A1 (en) 11 HYDROXYL DERIVATIVES OF BILIC ACIDS AND THEIR AMINO ACID CONJUGATES AS A PHARNESOID X-RECEPTOR MODULATORS
DOP2015000051A (en) ADALIMUMAB STABLE WATERPROOF FORMULATIONS
BR112015000229A2 (en) stable aqueous formulations of etanercept
BR112014009087A2 (en) xylitol stabilized etanercept formulations
EA201591003A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201691988A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
EA201591632A1 (en) CYTOTOXIC AND ANTIMITOTIC COMPOUNDS AND METHODS OF THEIR APPLICATION
MA37206B1 (en) Novel pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them
AR081681A1 (en) METHODS AND COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF b-GALACTOCEREBROSIDASA
PE20200404A1 (en) PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE
BR112016008576A2 (en) STABLE AQUEOUS FORMULATIONS OF ANTIBODIES AND PHARMACEUTICAL UNIT DOSAGE FORM
EA201591512A1 (en) Boron-containing molecules, methods and compositions
NI201300111A (en) PYRAZOLOSPIROKETONE DERIVATIVES FOR USE AS ACETYL-COA CARBOXYLASE INHIBITORS
EA201300258A1 (en) COMPOSITIONS BASED ON NALBUFIN AND THEIR APPLICATION
BR112014025041B8 (en) PHARMACEUTICAL COMPOSITION
BR112013022213A2 (en) parenteral administration of tapentadol
MA34981B1 (en) FORMULATIONS COMPRISING 2-AMINO-2-2-4-OCTYLPHENYL) ETHYL) PROPANE-1,3-DIOL
MX2016001422A (en) Pharmaceutical compositions of fingolimod.
AR090975A1 (en) N-ETIL-4-HYDROXYL-1-METHYL-5- (METHYL (2,3,4,5,6-PENTAHYDROXIHEXIL) AMINO) -2-OXO-N-PHENYL-1,2-DIHYDROCHINOLINE-3-CARBOXAMIDE
BR112014014786A2 (en) antibiotic formulations
BR112014030288A2 (en) pharmaceutical composition
EA201400444A1 (en) DERIVATIVES 2-OXOPYPERIDINYL
WO2013095319A3 (en) Formulations of flurbiprofen and diacerein
UY34839A (en) ANTIBIOTIC FORMULATIONS

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]